We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bactiguard Holding Ab | LSE:0QV2 | London | Ordinary Share | SE0005878741 | BACTIGUARD HOLDING ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.10 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 223.17M | -138.38M | -4.4576 | -5.41 | 748.16M |
STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Stefan Grass with extensive clinical experience as a physician and researcher, combined with senior positions in the pharmaceutical industry, has been recruited to a newly established, global role as Chief Medical and Technology Officer. He will assume his position in October 2019 and report to the CEO.
"As a physician and researcher specialized in anaesthesia and intensive care, Stefan Grass has extensive experience of the product portfolio Bactiguard offers and the complications healthcare associated infections lead to, both for patients and healthcare providers. He is genuinely development-oriented and after a number of intensive years in healthcare chose to take a role as Head of Medical Affairs in the pharmaceutical industry.
The combination of clinical, research-related and commercial experience makes him ideal for the new role in Bactiguard's management team and it is with pleasure that I welcome him on board," says Christian Kinch, CEO.
Stefan Grass holds a medical degree from the Karolinska Institute and is specialized in anaesthesia and intensive care. He has a PhD in neurophysiology, with focus on pain from the Karolinska University Hospital and has been active at the cardiothoracic department, among others.
Since 2011, Stefan Grass has been a member of the Nordic management team at CSL Behring, with responsibility for Medical Affairs and Market Access.
Stefan Grass is 47 years old and will take up his position in mid-October, with responsibility for Bactiguard's global clinical activities. He will also be involved in the development and marketing of the company's product portfolio for infection prevention and new licensing opportunities in various therapy areas.
In his role as Chief Medical and Technology Officer, Stefan Grass will report to the CEO and be part of Bactiguard's Executive Management team.
For further information, please contact:
Cecilia Edström, CFO
cell phone: +46-72-226-23-28
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/bactiguard-holding-ab--publ-/r/bactiguard-recruits-experienced-chief-medical-and-technology-officer,c2895238
The following files are available for download:
https://mb.cision.com/Main/9686/2895238/1100056.pdf | 190905 Bactiguard recruits experienced Chief Medical and Technology Officer |
https://news.cision.com/bactiguard-holding-ab--publ-/i/stefan-grass,c2676547 | Stefan Grass |
Copyright 2019 PR Newswire
1 Year Bactiguard Holding Ab Chart |
1 Month Bactiguard Holding Ab Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions